Available Technologies
# of Displayed Technologies: 1 / 1
A novel STK1-targeted small molecule as an antibiotic resistance breaker
TS-037880 — Inh2-B1 serves as a therapeutically important “antibiotic-resistance-breaker,” which enhances the bactericidal activity of Ceftriaxone/Cefotaxime against highly pathogenic MDRSA infection.
Highly pathogenic and multidrug-resistant Staphylococcus species encompasses methicillin-resistant strains of S. aureus (MDRSA) and S. epidermidis (MDRSE) that have developed resistance to multiple traditional antibiotics, including the 5th generation cephalosporin (Ceftaroline). Because of the re…
- College: College of Medicine (COM)
- Inventors: Pancholi, Vijay
- Licensing Officer: Csatary, Erika
